Jerry L.

• Provided leadership and guidance to the US business by overseeing the annual revenue planning and monthly forecasting process for a $360M business covering 23 products across three major categories • Vastly improved the company’s competitive intelligence by sourcing multiple third-party datasets to uncover industry and competitive insights on product adoption and pricing dynamics that helped to greatly shape commercial strategies for the business • Executed process improvement initiatives that included refining pricing policies and procedures, developing timely and informative performance dashboards, and establishing benchmark formats that improved forecasting accuracy • Managed numerous high-level consultancy projects for the business unit including salesforce design, compensation plan design, product pricing, and business intelligence • Ensured projects were completed on time, under budget, and within scope while managing changes in project scope, identifying potential issues, and devising contingency plans • Instrumental in enhancing KPIs by developing detailed dashboards, analytics, and reports to aid sales leaders and executives in gaining additional insights into business performance • Planned and launched five new key products covering pricing, inventory planning, competitive positioning, customer segmentation, performance measurement, and sales incentive design • Developed and implemented compensation plans for the sales and clinical teams to drive business performance including developing an appropriate and timely COVID incentive plan that built trust with the sales team • Exemplified outstanding technical and analytical skills by utilizing Excel and Tableau to conduct data analysis, visualization, and reporting to support data-driven strategic initiatives

• Developed the business unit’s strategic plan encompassing five of its most promising product opportunities • Managed all strategic marketing needs for a heart failure product including product strategy, patient targeting, market sizing, procedural development, physician requirements, FIH clinical strategy, and product animations

• Developed the region’s strategic plan and accompanying financials covering 10 countries • Supported various projects including product pricing across markets, regional product feasibility, performance measurement and budgeting

• Coordinated business development activities and drove analysis for 10+ targeted opportunities including: − JV with a pharmaceutical company to build a comprehensive surgical ophthalmic business in the Asia region − Acquisition of adjacent market opportunities and technologies (micro-invasive glaucoma surgical devices and implantable visual prostheses) to fill existing product/capability gaps (e.g., disposable instrumentation, knife manufacturing, vitrectomy cutters, and custom packaging solutions) Created presentations for the analyst conference and executive/board meeting

As business development head and member of the executive leadership team, directed all transaction stages including discovery, due diligence, valuation, business plan development, negotiations, corporate approval, and execution. • Led the completion of two key transactions to expand the portfolio in minimally invasive heart valve surgeries • Developed a new product development process to better assess and prioritize internal and external opportunities • Managed the development of annual performance targets and executive dashboards

Directed development of strategic plans, business reviews, annual operating plans, performance measures, performance reports and business/market intelligence. • Co-developed a minimally invasive valve surgery strategic plan that spanned across two business units (HVT and CSS) coordinating their product pipeline efforts, and resulted in 2 transactions and over 15 new product initiatives • Recommended strategic investments in the areas of atrial fibrillation, sub-valvular mitral valve repair, valve-in-valve development, and novel tissue treatments

Managed and supported the execution of acquisitions, divestitures, strategic alliances, licenses, and other transactions to drive the successful restructuring and reinvention of the company. • Completed 18+ transactions worth over $300M in value as part of a three-person team managing cross-functional deal teams and deal processes • Led valuation analyses (e.g., DCF, IRR, P&L and EPS impact) for over 70 potential deals • Developed financial models for important corporate litigation matters in the transcatheter markets • Distinguished as “Top Talent” at the company for multiple years and awarded additional cash bonus and stock compensation

Developed strategic plans for global franchises and key initiatives in collaboration with GMs and their leadership teams. • Created over 10 strategic plans in the peripheral/neurovascular, atrial fibrillation and transcatheter heart valve markets • Worked with CVPs to identify non-strategic business assets which resulted in 8 divestitures

Richard Reisman Fellow Graduated Cum Laude

Graduated Cum Laude